363
Views
3
CrossRef citations to date
0
Altmetric
REVIEW

Clinical Utility of Cabozantinib in the Treatment of Locally Advanced or Metastatic Differentiated Thyroid Carcinoma: Patient Selection and Reported Outcomes

&
Pages 343-350 | Received 26 Nov 2022, Accepted 10 Mar 2023, Published online: 11 Apr 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.